status: 200
content-location: http://rest.kegg.jp/get/map04723
server: Apache
date: Wed, 15 Oct 2014 15:09:01 GMT
content-type: text/plain

ENTRY       map04723                    Pathway
NAME        Retrograde endocannabinoid signaling
DESCRIPTION Endogenous cannabinoids (endocannabinoids) serve as retrograde messengers at synapses in various regions of the brain. The family of endocannabinoids includes at least five derivatives of arachidonic acid; the two best characterized are arachydonoyl ethanolamide (anandamide, AEA) and 2-arachydonoil glycerol (2AG). They are released from postsynaptic neurons upon postsynaptic depolarization and/or receptor activation. The released endocannabinoids then activate the CB1 receptors (CB1R) at presynaptic terminals and suppress the release of inhibitory transmitter GABA (depolarization-induced suppression of inhibition, DSI) or excitatory transmitter glutamate (depolarization-induced suppression of excitation, DSE) by inhibiting Ca2+ channels. Whereas DSI and DSE result in short-term synaptic plasticity, endocannabinoids also mediate long-term synaptic changes (eCB-LTD). Persistent activation of CB1 receptors over a period of minutes triggers eCB-LTD by a RIM1alpha-dependent mechanism.
CLASS       Organismal Systems; Nervous system
PATHWAY_MAP map04723  Retrograde endocannabinoid signaling
DISEASE     H00577  Syndromic X-linked mental retardation with epilepsy or seizures
DBLINKS     GO: 0071926
REFERENCE   PMID:17419048
  AUTHORS   Hashimotodani Y, Ohno-Shosaku T, Kano M
  TITLE     Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities.
  JOURNAL   Curr Opin Neurobiol 17:360-5 (2007)
REFERENCE   PMID:21531987
  AUTHORS   Ohno-Shosaku T, Tanimura A, Hashimotodani Y, Kano M
  TITLE     Endocannabinoids and retrograde modulation of synaptic transmission.
  JOURNAL   Neuroscientist 18:119-32 (2012)
REFERENCE   PMID:18084639
  AUTHORS   Basavarajappa BS
  TITLE     Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.
  JOURNAL   Curr Neuropharmacol 5:81-97 (2007)
REFERENCE   PMID:16968947
  AUTHORS   Pacher P, Batkai S, Kunos G
  TITLE     The endocannabinoid system as an emerging target of pharmacotherapy.
  JOURNAL   Pharmacol Rev 58:389-462 (2006)
REFERENCE   PMID:15340387
  AUTHORS   Di Marzo V, Bifulco M, De Petrocellis L
  TITLE     The endocannabinoid system and its therapeutic exploitation.
  JOURNAL   Nat Rev Drug Discov 3:771-84 (2004)
REFERENCE   PMID:17404373
  AUTHORS   Hashimotodani Y, Ohno-Shosaku T, Kano M
  TITLE     Endocannabinoids and synaptic function in the CNS.
  JOURNAL   Neuroscientist 13:127-37 (2007)
REFERENCE   PMID:19126760
  AUTHORS   Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M
  TITLE     Endocannabinoid-mediated control of synaptic transmission.
  JOURNAL   Physiol Rev 89:309-80 (2009)
REFERENCE   PMID:19640475
  AUTHORS   Regehr WG, Carey MR, Best AR
  TITLE     Activity-dependent regulation of synapses by retrograde messengers.
  JOURNAL   Neuron 63:154-70 (2009)
REFERENCE   PMID:17636069
  AUTHORS   Benarroch E
  TITLE     Endocannabinoids in basal ganglia circuits: implications for Parkinson disease.
  JOURNAL   Neurology 69:306-9 (2007)
REFERENCE   PMID:16085309
  AUTHORS   Ohno-Shosaku T, Hashimotodani Y, Maejima T, Kano M
  TITLE     Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium.
  JOURNAL   Cell Calcium 38:369-74 (2005)
REFERENCE   PMID:18801434
  AUTHORS   Harkany T, Mackie K, Doherty P
  TITLE     Wiring and firing neuronal networks: endocannabinoids take center stage.
  JOURNAL   Curr Opin Neurobiol 18:338-45 (2008)
REFERENCE   PMID:18515270
  AUTHORS   Hosking RD, Zajicek JP
  TITLE     Therapeutic potential of cannabis in pain medicine.
  JOURNAL   Br J Anaesth 101:59-68 (2008)
REFERENCE   PMID:21187849
  AUTHORS   Di Marzo V
  TITLE     Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.
  JOURNAL   Nat Neurosci 14:9-15 (2011)
REFERENCE   PMID:18948642
  AUTHORS   McPartland JM
  TITLE     The endocannabinoid system: an osteopathic perspective.
  JOURNAL   J Am Osteopath Assoc 108:586-600 (2008)
REFERENCE   PMID:17553427
  AUTHORS   Chevaleyre V, Heifets BD, Kaeser PS, Sudhof TC, Castillo PE
  TITLE     Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha.
  JOURNAL   Neuron 54:801-12 (2007)
REFERENCE   PMID:19553483
  AUTHORS   Lafourcade CA
  TITLE     Presynaptic mechanisms of endocannabinoid-mediated long-term depression in the hippocampus.
  JOURNAL   J Neurophysiol 102:2009-12 (2009)
REFERENCE   PMID:21117095
  AUTHORS   Ueda N, Tsuboi K, Uyama T, Ohnishi T
  TITLE     Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
  JOURNAL   Biofactors (2010)
REFERENCE   PMID:14978245
  AUTHORS   Guo J, Ikeda SR
  TITLE     Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly  rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
  JOURNAL   Mol Pharmacol 65:665-74 (2004)
KO_PATHWAY  ko04723
///
